Chrome Extension
WeChat Mini Program
Use on ChatGLM

Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer.

Journal of immunotherapy and precision oncology(2023)

Cited 0|Views29
No score
Abstract
Bone metastasis and absolute lymphocyte count below normal range at phase I study entry portend poor survival in patients with recurrent or metastatic cervical cancer.
More
Translated text
Key words
lymphopenia,metastatic cervical cancer,phase I trial prognosis,recurrent cervical cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined